Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Expenses:
Research and development	$ 2,521,950	$ 3,712,584
General and administrative	2,936,886	3,474,965
Total Operating Expenses	5,458,836	7,187,549
Loss From Operations	(5,458,836)	(7,187,549)
Other Income (Expense):
Other income (expense), net	70,993	(7,073)
Interest expense	(454,003)	(145,237)
Interest income	102,480	194
Net Loss	$ (5,739,366)	$ (7,339,665)
Net Loss Per Share
Net Loss Per Share - Basic	$ (0.15)	$ (0.24)
Net Loss Per Share - Diluted	$ (0.15)	$ (0.24)
Weighted Average Number of Common Shares Outstanding
Weighted Average Number of Common Shares Outstanding - Basic	37,410,587	30,008,194
Weighted Average Number of Common Shares Outstanding - Diluted	37,410,587	30,008,194